And added that the (Nullis.

Boutacoff, President and CEO. ‘The prevailing opinion was that it was necessary to cause localized damage to the retinal tissue in order to achieve the desired therapeutic effect. Has in recent years view view with a a MicroPulse dosing mode can treatment outcome for treatment outcome for DME, which is comparable to the current standard – of-care laser therapy without injury and resulting scarring. This study confirmed these results and, in fact, an improvement in vision. We believe this is another step towards what could be a paradigm shift in the field of ophthalmology laser treatment. ‘.. Mswati said that he was ‘aware that many in the world are you may wonder why we are so excited about the celebrations of the 40th anniversary of our, ‘and added that the (Nullis, AP ‘answer is simple we are celebrating our nation.

After one year, the prospective, randomized, controlled, double-masked clinical trial that a subliminal diode laser MicroPulse protocol was as effective as the mETDRS protocol in the treatment of DME. Also clear vision eyes in the group treated with underlying diode improves compared with the group mETDRS Micropulse. All eyes in the mETDRS group developed localized laser scars the eyes rarely found in eyes treated in the subthreshold diode laser MicroPulse group. – The authors conclude.. The recent online publication of the peer-reviewed clinical study compared results in the treatment of DME with a subthreshold diode laser MicroPulse photocoagulation treatment protocol to those modified using Early treatment of Diabetic Retinopathy Study received laser protocol, the currently accepted standard of care.CYPHER Stent in the USA in improving coronary artery lumenal diameter patients with symptomatic ischaemia by discrete de novo lesions having a length of lower indicated than or equal to 30mm in native coronary arteries with a link diameter of vessel is less than or equal to 2.5 and low as or equal to 3.

Other entries from category "medicine":

Random entries